Birdwatch Note Rating
2023-06-28 01:33:45 UTC - HELPFUL
Rated by Participant: B6B6625BC9E5E7753A723787520D6DFB26F84176B599FCA8FDB14A8F7E0FFBB1
Participant Details
Original Note:
Ketamine, an anesthetic used for many years, was sanctioned by the FDA in 2019 as a nasal spray for individuals suffering from depression that has been resistant to other treatments. Studies have shown it to be as effective as ECT at treating depression. Harvard Health https://www.health.harvard.edu/blog/ketamine-for-treatment-resistant-depression-when-and-where-is-it-safe-202208092797
All Note Details